共 112 条
[1]
Goodman CW(2021)10. Cardiovascular disease and risk management: standards of medical care in diabetes—2022 Diabetes Care 45 S144-S174
[2]
Brett AS(2021)12. Retinopathy, neuropathy, and foot care: standards of medical care in diabetes—2022 Diabetes Care 45 S185-S194
[3]
Largeau B(2019)A clinical overview of off-label use of gabapentinoid drugs JAMA Intern Med 179 695-94
[4]
Hjalmarsson C(2022)Gabapentinoid-induced peripheral edema and acute heart failure: a translational study combining pharmacovigilance data and in vitro animal experiments Biomed Pharmacother 149 85-284
[5]
Greenberg B(2021)Risk of stroke in patients with heart failure and sinus rhythm: data from the Swedish Heart Failure Registry ESC Heart Fail 8 277-447
[6]
Berger JS(2019)Ejection fraction, B-type natriuretic peptide and risk of stroke and acute myocardial infarction among patients with heart failure Clin Cardiol 42 436-187
[7]
Kang S-H(2019)Risk of ischemic stroke in patients newly diagnosed with heart failure: focus on patients without atrial fibrillation J Cardiac Fail 25 182-158
[8]
Fanola CL(2017)Risk of stroke in congestive heart failure with and without atrial fibrillation Int J Cardiol 248 148-2314
[9]
Go AS(2020)Incident heart failure and long-term risk for venous thromboembolism J Am Coll Cardiol 75 2303-520
[10]
Kerlin BA(2021)Primary nephrotic syndrome and risks of ESKD, cardiovascular events, and death: the Kaiser permanente nephrotic syndrome study JASN 32 513-148